Educational Interventions on Diabetic Foot Care

May 18, 2022 updated by: Gabriela Ferreira, University of Minho

Impact of Educational Interventions on Diabetic Foot Self-care: A Pragmatic Randomized Controlled Trial

Diabetes mellitus currently affects 463 million people worldwide. One of the most serious complications of diabetes is the diabetic foot. Adequate foot care behaviours reduce the risk of ulcers, infections, and amputations, and improve the quality of life, in these patients.

This Pragmatic Randomized Controlled Trial aims to analyse the impact of different educational strategies - an instructive video (Video Watching Group - Experimental Group 1) compared with a leaflet on foot care with real-time guided reading (Real-Time Leaflet Reading Group - Experimental Group 2) and with standard teaching on diabetic foot care (Standard Care - Control Group) - on adherence and knowledge regarding diabetic foot care, as well as on patient's perception of their foot health. Participants will be assessed at the first consultation of the diabetic foot (T0), about two weeks after the first assessment (T1), and three months after the T0 in a follow-up assessment (T2), with T1 and T2 being performed through telephone calls, after obtaining the patients' consent.

The results of the present study will inform educational interventions regarding foot care adherence in patients with diabetic foot, in order to decrease the likelihood of developing diabetic foot ulcers and, consequently, to reduce amputation rates and the several associated costs, contributing to improving patients' quality of life.

Study Overview

Detailed Description

Specific Aims

  1. To analyze the contribution of sociodemographic, clinical, and psychological variables to diabetic foot care adherence and knowledge, and perceived foot health, over time.
  2. To analyze the differences between groups over time in diabetic foot care adherence, knowledge on foot care, and perceived foot health.
  3. To examine the mediating role of representations about diabetic foot in the relationship between knowledge about foot care and adherence to diabetic foot care, over time, controlling for health literacy.
  4. To examine the moderating role of foot pain, foot function, and footwear between representations about diabetic foot and adherence to diabetic foot care/ perceived foot health, over time.

Data Analysis:

Generalized Mixed Models, which allow examining changes over time including longitudinal mediation and moderation.

Sample size calculation:

Considering a dropout rate of 10%, the sample size required is 60 patients (20 per group).

Procedure:

Participants will be assessed at the first consultation of the diabetic foot (T0), about two weeks after the first assessment (T1), and three months after the T0 in a follow-up assessment (T2), with T1 and T2 being performed through telephone calls.

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Porto, Portugal, 4099-001
        • Centro Hospitalar Universitario do Porto
    • Porto
      • Penafiel, Porto, Portugal, 4564-007
        • Clínica do Pé Diabético, Centro Hospitalar do Tâmega e Sousa

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Diagnosis of Diabetes mellitus;
  • Diagnosis of Diabetic Foot;
  • To benefit from the first assessment and follow-up at the Multidisciplinary Diabetic Foot Consultation of the hospitals where data collection will take place.

Exclusion Criteria:

  • Presence of clinical dementia described in the patient's clinical record;
  • Cognitive disability to answer the questionnaires;
  • Severe visual and/or hearing impairment.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Video Watching Group
Participants will watch an instructive video on diabetic foot care and will receive face-to-face teaching on diabetic foot care.
In the video, the diabetic foot care is presented verbally and appropriately captioned, as well as exemplified by real patients and health professionals from the hospital
Face-to-face teaching includes the teaching about diabetic foot care during the consultation by health professionals.
EXPERIMENTAL: Real-time Leaflet Reading Group
Participants will receive a leaflet with diabetic foot care information, whose reading will be guided in real-time by the Researcher, and will also receive face-to-face teaching on diabetic foot care.
Face-to-face teaching includes the teaching about diabetic foot care during the consultation by health professionals.
The leaflet has information about diabetic foot care. Researcher will guide its reading with patients.
ACTIVE_COMPARATOR: Standard Care Group
Participants will receive the standard care that includes face-to-face teaching about diabetic foot care and will take a leaflet on diabetic foot care to read at home.
Face-to-face teaching includes the teaching about diabetic foot care during the consultation by health professionals.
Patients receive a leaflet about diabetic foot care to read at home.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Adherence to the diabetic foot care behaviours
Time Frame: Changes from baseline to two weeks post-test and after a three month follow-up
Adherence to foot care behaviors will be assessed through the Nottingham Assessment of Functional Foot Care (Lincoln, Jeffcoate, Ince, Smith, & Radford, 2007). Composed of 29 items whose answers are given on a Likert scale ranging from 0 to 3. Higher scores correspond to a higher frequency of foot care behaviors.
Changes from baseline to two weeks post-test and after a three month follow-up
Adherence to the diabetic foot care behaviours
Time Frame: Changes from baseline to two weeks post-test and after a three month follow-up
The level of foot self-care (indirect measure of adherence) will be assessed through the subscale of Foot Care of the Summary Diabetes Self-Care Activities Questionnaire (Original Version by Toobert, Hampson, & Glasgow, 2000; Portuguese Version by Bastos, Severo, & Lopes, 2007). Composed of 3 items in which patients are asked how many of the last seven days did they perform the respective foot care behaviour. Therefore, answers are given on a scale between 0 and 7, and its score is calculated through the mean number of days. Higher scores indicate higher levels of foot self-care.
Changes from baseline to two weeks post-test and after a three month follow-up
Knowledge on foot care
Time Frame: Changes from baseline to two weeks post-test and after a three month follow-up
Knowledge on foot care will be assessed through the Questionnaire on Knowledge of Foot Care (Hasnain & Sheikh, 2009). Each correct answer is scored with 1 point and higher scores indicate better knowledge about foot care.
Changes from baseline to two weeks post-test and after a three month follow-up
General foot health
Time Frame: Changes from baseline to two weeks post-test and after a three month follow-up
General foot health will be assessed through the respective subscale of the Foot Health Status Questionnaire (FHSQ; Bennett, Patterson, Wearing, & Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to the perception of poor foot health state/condition and 100 to the perception of excellent foot health.
Changes from baseline to two weeks post-test and after a three month follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Representations about diabetic foot
Time Frame: Changes from baseline to two weeks post-test and after a three month follow-up
Representations about diabetic foot will be assessed through the Illness Perception Questionnaire - Brief (IPQ-B; Figueiras et al., 2010). The response scale ranges from 0 to 10. Higher scores indicate more threatening representations regarding diabetic foot.
Changes from baseline to two weeks post-test and after a three month follow-up

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Foot pain
Time Frame: Baseline (T0), two weeks post-test (T1), three months follow-up (T2)
Foot pain will be assessed through the respective subscale of the Foot Health Status Questionnaire (Bennett, Patterson, Wearing, & Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to significant or extreme foot pain and 100 to no foot pain or discomfort.
Baseline (T0), two weeks post-test (T1), three months follow-up (T2)
Foot function
Time Frame: Baseline (T0), two weeks post-test (T1), three months follow-up (T2)
Foot function will be assessed through the respective subscale of the Foot Health Status Questionnaire (FHSQ; Bennett, Patterson, Wearing, & Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to severe limitation in the performance of physical activities because of the feet and 100 to no limitation.
Baseline (T0), two weeks post-test (T1), three months follow-up (T2)
Footwear
Time Frame: Baseline (T0), two weeks post-test (T1), three months follow-up (T2)
Footwear will be assessed through the respective subscale of the Foot Health Status Questionnaire (FHSQ; Bennett, Patterson, Wearing, & Baglioni, 1998). Scores are transformed into a scale of 0 to 100, where 0 corresponds to severe problems obtaining appropriate footwear and 100 to no problems.
Baseline (T0), two weeks post-test (T1), three months follow-up (T2)
Clinical Data
Time Frame: Baseline (T0)
Clinical variables (e.g., HbA1c levels, presence/absence of active ulcer and duration of diabetic foot ulcer, recommendation to use therapeutic footwear) will be assessed through a Clinical Questionnaire developed for this study
Baseline (T0)
Health literacy
Time Frame: Baseline (T0)
Health literacy will be assessed through the Medical Term Recognition Test (METER; Paiva et al., 2014).
Baseline (T0)
Sociodemographic data
Time Frame: Baseline (T0)
The sample will be characterized using a Sociodemographic Questionnaire developed for this study (e.g. age, marital status, gender, socio-economic level).
Baseline (T0)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Gabriela Ferreira, Master, School of Psychology, University of Minho

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

March 8, 2021

Primary Completion (ACTUAL)

December 15, 2021

Study Completion (ACTUAL)

December 31, 2021

Study Registration Dates

First Submitted

March 14, 2021

First Submitted That Met QC Criteria

March 20, 2021

First Posted (ACTUAL)

March 23, 2021

Study Record Updates

Last Update Posted (ACTUAL)

May 19, 2022

Last Update Submitted That Met QC Criteria

May 18, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus

Clinical Trials on Instructive video on diabetic foot care

3
Subscribe